Close Menu

UC Berkeley

Eighteen researchers call for a temporary stop to all clinical uses of human germline editing in a piece appearing in Nature.

The biotech startup, which had been working with Cas12 and Cas13, has now licensed the recently discovered Cas14 protein from UC Berkeley.

CRISPR technology has made its way around the world, but in the wake of the He Jiankui controversy, the industry is asking what recourse it has against misuse.

For the Future

Rolling Stone calls the University of California, Berkeley's Jennifer Doudna one of the women who is shaping the future.

This Week in Science

In Science this week: the synthetic genetic system hachimoji, and more.

Business Insider reports on efforts to apply genetic engineering to cacao plants.

This Week in Nature

In Nature this week: new CRISPR nuclease described, gut bacteria reference, and more.

February 5, 2019: Researchers are searching for a range of gene-editing enzyme tools, the Los Angeles Times reports.

Two new studies identified extensive RNA scaffolds underlying the increased editing efficiency of these nucleases.

Which Way to Go

The New York Times reports on international efforts to oversee and regulate gene-editing work.

Pages

Matt Hancock, the UK health secretary, is calling for the swift rollout of predictive genetic tests, the Guardian reports.

A WHO panel is calling for a global registry of human germline gene-editing projects, according to Stat News.

Vox writes that lab mishaps involving pathogens are quite common.

In Genome Biology this week: analysis of wild and cultivated peach genomes, Hi-C-based pipeline for assembling microbial genomes from metagenomic data, and more.